Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.1102
-0.0102 (-8.51%)
At close: Mar 20, 2026
Centogene Market Cap
Centogene has a market cap or net worth of $3.28 million as of March 20, 2026. Its market cap has decreased by -78.01% in one year.
Market Cap
3.28M
Enterprise Value
n/a
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 5, 2019, Centogene's market cap has increased from 3.22M to 3.28M, an increase of 2.00%. That is a compound annual growth rate of 0.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.28M | 4.90% |
| Dec 31, 2025 | 3.13M | -20.39% |
| Dec 31, 2024 | 3.93M | -88.24% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Interpace Biosciences | 45.69M |
| Bioqual | 33.55M |
| Longduoduo Company | 15.31M |
| Aspira Women's Health | 13.71M |
| Psychemedics | 8.57M |
| Stella Diagnostics | 4.82M |
| Hypha Labs | 4.06M |
| InVitro International | 1.98M |